https://www.selleckchem.com/pr....oducts/deferiprone.h
0031), a lower median TSQM-9 global score (p 0.0001), and higher median B-IPQ score (p 0.0001). The proportion of patients who had exacerbations during the previous year was higher in patients with suboptimal COPD awareness than in those with DACQ score ≥80 (42.8 vs. 21.4%, p = 0.0009). During the 12-month observation period, illness perception, adherence, and treatment satisfaction were found to be independent factors significantly associated with level of disease awareness. The results of our post hoc analysis suggest th
Like
Comment
Share
